Vaccination of colorectal cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) induces immune responses which correlate with disease control: a phase I/II trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples